Clark W F
Department of Medicine, University of Western Ontario, London.
Clin Invest Med. 1994 Dec;17(6):588-601.
The treatment of patients with clinical lupus nephritis is based on a combination of our understanding of the natural history of the disease, a large number of anecdotal reports, and a small number of studies which demonstrate statistical treatment benefits. This review is directed towards the treatments (immunosuppressive, general therapy, and end-stage renal failure management) which have been demonstrated to have been, or not to have been, beneficial. Although the prognosis of patients with lupus nephritis is undergoing continuous improvement, this may relate as much to changes in general treatment measures as to specific immunosuppressive schedules.
临床狼疮性肾炎患者的治疗基于我们对该疾病自然史的理解、大量轶事报道以及少数显示出统计学治疗益处的研究。本综述针对已被证明有益或无益的治疗方法（免疫抑制、一般治疗和终末期肾衰竭管理）。尽管狼疮性肾炎患者的预后在不断改善，但这可能与一般治疗措施的变化以及特定免疫抑制方案的变化同样相关。
